Effect of Gender on Atrial Fibrillation Ablation Outcomes Using a Propensity Score-matched Analysis

Overview

Journal Heart Rhythm O2

Date 2023 Jun 16

PMID 37323996

Authors

Mohammed Al-Sadawi

Faisal Aslam

Chad Gier

Saadat Aleem

Hina Ijaz

Robin Jacobs

Kerry Cao

Mahmoud Alsaiqali

Abhijeet Singh

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have shown that women with atrial fibrillation (AF) have a higher incidence of recurrence and non-pulmonary vein (non-PV) triggers. However, there remains an incomplete understanding of the impact of gender on AF ablation strategies and outcomes.

Objective: The purpose of this study was to evaluate the impact of gender on AF ablation outcomes.

Methods: We analyzed 1568 AF ablations in 1412 patients (34% female) performed at a single tertiary care center between January 2013 and July 2021. Patients were followed for at least 6 months (mean 34 months) for detection of AF recurrence, complications, and emergency department visits/hospitalizations. The effect was assessed by multivariate logistic regression analysis using propensity score matching (PSM).

Results: Mean age was 64 years, and mean body mass index (BMI) was 31 kg/m. Seventy-seven percent of patients underwent ablations. Twenty-seven percent of patients had persistent AF, with a recurrence rate of 37%. There was no difference in AF recurrence when stratified by gender (hazard ratio [HR] 1.15; 95% confidence interval [CI] 0.92-1.43; >.05) and age. After PSM gender 1:1 (criteria: age, type of AF, hypertension, diabetes mellitus, and BMI; n = 888 patients), there was no difference in AF recurrence or procedure-related complications. Having a history of persistent AF (HR 1.54; 95% CI 1.18-1.99; = .001) predisposed to recurrence of AF. Persistent AF (HR 2.99; 95% CI 1.94-4.78; <.001) and age >70 years (HR 1.03; 95% CI 1.02-1.05; <.001) were associated with the need for additional substrate modification with no difference based on gender.

Conclusion: There was no difference in overall safety or efficacy outcomes between genders after AF ablation.

References

du Fay de Lavallaz J, Badertscher P, Kobori A, Kuck K, Brugada J, Boveda S . Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: An individual patient data meta-analysis. Heart Rhythm. 2020; 17(8):1232-1240. DOI: 10.1016/j.hrthm.2020.04.020. View

Kuck K, Brugada J, Furnkranz A, Chun K, Metzner A, Ouyang F . Impact of Female Sex on Clinical Outcomes in the FIRE AND ICE Trial of Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2018; 11(5):e006204. DOI: 10.1161/CIRCEP.118.006204. View

Asad Z, Yousif A, Khan M, Al-Khatib S, Stavrakis S . Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019; 12(9):e007414. DOI: 10.1161/CIRCEP.119.007414. View

Piccini J, Lopes R, Kong M, Hasselblad V, Jackson K, Al-Khatib S . Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol. 2009; 2(6):626-33. DOI: 10.1161/CIRCEP.109.856633. View

Calkins H, Hindricks G, Cappato R, Kim Y, Saad E, Aguinaga L . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm. 2017; 33(5):369-409. PMC: 5634725. DOI: 10.1016/j.joa.2017.08.001. View

Khan S, Raghu Subramanian C, Khan M, Lone A, Talluri S, Han J . Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation. J Am Heart Assoc. 2022; 11(5):e024233. PMC: 9075084. DOI: 10.1161/JAHA.121.024233. View

Russo A, Zeitler E, Giczewska A, Silverstein A, Al-Khalidi H, Cha Y . Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial. Circulation. 2021; 143(7):661-672. PMC: 8032462. DOI: 10.1161/CIRCULATIONAHA.120.051558. View

Lippi G, Sanchis-Gomar F, Cervellin G . Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2020; 16(2):217-221. DOI: 10.1177/1747493019897870. View

Sandorfi G, Rodriguez-Manero M, Saenen J, Baluja A, Bories W, Huybrechts W . Less Pulmonary Vein Reconnection at Redo Procedures Following Radiofrequency Point-by-Point Antral Pulmonary Vein Isolation With the Use of Contemporary Catheter Ablation Technologies. JACC Clin Electrophysiol. 2018; 4(12):1556-1565. DOI: 10.1016/j.jacep.2018.09.020. View

10.

Kaiser D, Fan J, Schmitt S, Than C, Ullal A, Piccini J . Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. JACC Clin Electrophysiol. 2018; 2(6):703-710. PMC: 5881580. DOI: 10.1016/j.jacep.2016.04.014. View

11.

Westerman S, Wenger N . Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes. Curr Cardiol Rev. 2018; 15(2):136-144. PMC: 6520576. DOI: 10.2174/1573403X15666181205110624. View

12.

Piccini J, Hammill B, Sinner M, Jensen P, Hernandez A, Heckbert S . Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes. 2012; 5(1):85-93. PMC: 3332107. DOI: 10.1161/CIRCOUTCOMES.111.962688. View

13.

Patel D, Mohanty P, Di Biase L, Sanchez J, Shaheen M, Burkhardt J . Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2009; 7(2):167-72. DOI: 10.1016/j.hrthm.2009.10.025. View

14.

Cheung J, Cheng E, Wu X, Yeo I, Christos P, Kamel H . Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. Eur Heart J. 2019; 40(36):3035-3043. PMC: 7963138. DOI: 10.1093/eurheartj/ehz151. View

15.

Patel N, Deshmukh A, Thakkar B, Coffey J, Agnihotri K, Patel A . Gender, Race, and Health Insurance Status in Patients Undergoing Catheter Ablation for Atrial Fibrillation. Am J Cardiol. 2016; 117(7):1117-26. DOI: 10.1016/j.amjcard.2016.01.040. View

16.

Takigawa M, Kuwahara T, Takahashi A, Watari Y, Okubo K, Takahashi Y . Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013; 168(3):1984-91. DOI: 10.1016/j.ijcard.2012.12.101. View

17.

Kornej J, Borschel C, Benjamin E, Schnabel R . Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. Circ Res. 2020; 127(1):4-20. PMC: 7577553. DOI: 10.1161/CIRCRESAHA.120.316340. View

18.

Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D . Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019; 21(10):1509-1518. DOI: 10.1093/europace/euz179. View

19.

Yunus F, Perino A, Holmes D, Matsouaka R, Curtis A, Ellenbogen K . Sex Differences in Ablation Strategy, Lesion Sets, and Complications of Catheter Ablation for Atrial Fibrillation: An Analysis From the GWTG-AFIB Registry. Circ Arrhythm Electrophysiol. 2021; 14(11):e009790. DOI: 10.1161/CIRCEP.121.009790. View

20.

Ninomiya Y, Inoue K, Tanaka N, Okada M, Tanaka K, Onishi T . Absence of first-pass isolation is associated with poor pulmonary vein isolation durability and atrial fibrillation ablation outcomes. J Arrhythm. 2021; 37(6):1468-1476. PMC: 8637089. DOI: 10.1002/joa3.12629. View